Abo, Geniba H.

HRN: 23-35-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2023
AMPICILLIN 1GM (VIAL)
07/19/2023
07/22/2023
IV
2g
Q6
PROM X 7 Hrs
Waiting Final Action 
07/19/2023
CO-AMOXICLAV 625MG (TAB)
07/19/2023
07/26/2023
PO
625mg
BID X 7 Days
PROM X 24 Hours
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: